Insider Transactions in Q2 2025 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.47%
|
-
|
|
Jun 30
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+6.86%
|
-
|
|
Jun 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-13.25%
|
$70,000
$7.78 P/Share
|
|
May 31
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.49%
|
-
|
|
May 31
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+6.46%
|
-
|
|
May 22
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,220
+4.93%
|
$41,100
$5.1 P/Share
|
|
May 19
2025
|
Jeffrey S. Hackman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,965
+48.21%
|
$83,790
$6.99 P/Share
|
|
May 16
2025
|
Jeffrey S. Hackman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,035
+50.0%
|
$6,210
$6.75 P/Share
|
|
May 16
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,667
+9.98%
|
-
|
|
May 16
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
16,667
-19.17%
|
$100,002
$6.78 P/Share
|
|
May 16
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
33,334
+27.72%
|
-
|
|
May 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-15.73%
|
$60,000
$6.31 P/Share
|
|
Apr 30
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+3.68%
|
-
|
|
Apr 30
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.77%
|
-
|
|
Apr 11
2025
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,409
-2.55%
|
$5,636
$4.95 P/Share
|
|
Apr 11
2025
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
2,173
+3.79%
|
$4,346
$2.3 P/Share
|
|
Apr 04
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-14.05%
|
$50,000
$5.25 P/Share
|